Lymphatica

Company created in 2017

Grant in 2016, Seed in 2018

Development and testing of an implantable solution for treating lymphedema, one of the most common side effect of cancer treatment.

Lymphatica Medtech SA
Chemin de la Raye 13
1024 Ecublens